2023 Regional Board Member Elections

2023 is an election year!

The time has come again for WHA members to have a say about who is representing you at a regional level.   

Four new board members for the AFRO, EMRO, EURO and WPRO regions will be elected in January 2024 to begin their two-year term.    

We call on WHA member organisations to nominate candidates to represent your region.    

How to nominate a candidate?   

  1. Carefully review the role description with a particular focus on the person specification to ensure the person you have in mind fulfils all of the criteria for the role. The candidate must reside in the country in which the nominating organisation is based.  

  1. Return the nomination form, completed in English, to elections@worldhepatitisalliance.org by 5 November 2023 including ‘WHA 2023 Election’ in the subject line. Please note that the front page of the form must be completed by yourself and page 2-4 by the candidate; failure to follow the instructions stipulated may result in the nomination not being considered.  

Please note only one nominee from each country will be accepted. Where more than one nominee is put forward by a single country, WHA will ask voting members within that country to rank their first and second choice nominee. The candidate with more than 51% of the votes received will be the one put forward.  

Don’t miss the deadline!  

Please do not hesitate to contact us at elections@worldhepatitisalliance.org should you have any queries. 

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close